Fundraising FoxDNA Lite
San Francisco, US · 3 known investors
Find your way into DNA Lite
Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium. It focuses on oral mRNA medicines.
Founders & leadership
MA
Mubhij AhmadNamed on SEC filing
DR
David RabukaNamed on SEC filing
TP
Timothy Paul DayNamed on SEC filing
Board
AC
DL
Investors · 3
Berkeley Catalystlisted by Berkeley CatalystBerkeley
How we know: the VCSheet dataset · Not right? Tell us
Blue Bear Ventureslisted by Blue Bear VenturesBerkeley · $100K – $400K
How we know: Blue Bear Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$5.6M disclosed across 1 round · 2022
▶$5.6MraisedApr 2022 · 18 investors · BiotechnologyRule 506(b)
▶$5.6MraisedApr 2022 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mubhij AhmadExecutive Officer, Director
- David RabukaDirector
- Timothy Paul DayDirector
- Andrew Cain McClaryDirector
- Drew LanzaDirector
- Offering amount
- $8.9M
- Amount sold
- $5.6M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does DNA Lite do?
- Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium. It focuses on oral mRNA medicines.
- Who are DNA Lite's investors?
- DNA Lite's investors include Berkeley Catalyst, Blue Bear Ventures, KdT Ventures.
- How much funding has DNA Lite raised?
- DNA Lite has disclosed $5.6M raised across 1 round.
- Where is DNA Lite headquartered?
- DNA Lite is headquartered in San Francisco, US.